美国 · SEC FORM 4
CorMedix Inc.
CRMD · Nasdaq · CIK 0001410098 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
0 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-10-23 · Kaplan Myron.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 15,422,728
- 上期报告
- 16,202,272
- 日均成交量
- 815,972
- 回补天数
- 18.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-10-23 | Kaplan Myron | 买入 (P) | Common Stock | 25,000 | USD 11.02 | USD 275,500 | SEC 申报 ↗ |
| 2024-10-31 | Mistry Erin | 买入 (P) | Common Stock | 1,500 | USD 9.99 | USD 14,985 | SEC 申报 ↗ |
| 2024-03-13 | Todisco Joseph | 买入 (P) | Common Stock | 13,561 | USD 3.74 | USD 50,718 | SEC 申报 ↗ |
| 2023-12-15 | DUNTON ALAN W | 买入 (P) | Common Stock | 3,000 | USD 3.30 | USD 9,900 | SEC 申报 ↗ |
| 2023-12-14 | DUNTON ALAN W | 买入 (P) | Common Stock | 3,000 | USD 3.45 | USD 10,350 | SEC 申报 ↗ |
| 2023-11-17 | Mistry Erin | 买入 (P) | Common Stock | 1,000 | USD 4.00 | USD 4,000 | SEC 申报 ↗ |
| 2023-09-08 | Todisco Joseph | 买入 (P) | Common Stock | 10,000 | USD 3.71 | USD 37,100 | SEC 申报 ↗ |
| 2023-05-18 | Kaplan Myron | 买入 (P) | Common Stock | 6,000 | USD 4.54 | USD 27,240 | SEC 申报 ↗ |
| 2023-05-17 | Todisco Joseph | 买入 (P) | Common Stock | 5,000 | USD 4.58 | USD 22,900 | SEC 申报 ↗ |
| 2023-05-17 | Stewart Robert A | 买入 (P) | Common Stock | 10,000 | USD 4.37 | USD 43,700 | SEC 申报 ↗ |
| 2023-05-17 | DUNTON ALAN W | 买入 (P) | Common Stock | 3,000 | USD 4.33 | USD 12,990 | SEC 申报 ↗ |
| 2023-05-17 | Costa Paulo F | 买入 (P) | Common Stock | 10,000 | USD 4.65 | USD 46,500 | SEC 申报 ↗ |
| 2022-11-15 | Todisco Joseph | 买入 (P) | Common Stock | 20,000 | USD 3.82 | USD 76,400 | SEC 申报 ↗ |
| 2022-08-24 | Todisco Joseph | 买入 (P) | Common Stock | 4,700 | USD 3.92 | USD 18,424 | SEC 申报 ↗ |
| 2022-05-17 | Kaplan Myron | 买入 (P) | Common Stock | 5,000 | USD 3.78 | USD 18,900 | SEC 申报 ↗ |
Form 4 申报证据
49 transaction lines in the latest 365-day window; 160 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Dillione Janet | 期权行权／转换 (M) | Common Stock | 48,909 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-29 | Zelnick Kaufman Beth | 代扣税 (F) | Common Stock | 8,424 | USD 8.30 | USD 69,919 | SEC 申报 ↗ |
| 2026-08-29 | Hurlburt Elizabeth | 代扣税 (F) | Common Stock | 8,076 | USD 8.30 | USD 67,031 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Dillione Janet | 期权行权／转换 (M) | Common Stock | 48,909 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-29 | Zelnick Kaufman Beth | 代扣税 (F) | Common Stock | 8,424 | USD 8.30 | USD 69,919 | SEC 申报 ↗ |
| 2026-08-29 | Hurlburt Elizabeth | 代扣税 (F) | Common Stock | 8,076 | USD 8.30 | USD 67,031 | SEC 申报 ↗ |
| 2026-08-29 | Blum Susan | 代扣税 (F) | Common Stock | 8,424 | USD 8.30 | USD 69,919 | SEC 申报 ↗ |
| 2026-02-04 | Zelnick Kaufman Beth | 奖励／授予 (A) | Common Stock | 36,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | Todisco Joseph | 奖励／授予 (A) | Common Stock | 77,156 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-04 | Hurlburt Elizabeth | 奖励／授予 (A) | Common Stock | 36,006 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | Stewart Robert A | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | Lefkowitz Steven W | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | Kaplan Myron | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | Duncan Gregory Scott | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | Dillione Janet | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-26 | DUNTON ALAN W | 奖励／授予 (A) | Common Stock | 30,453 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-23 | Zelnick Kaufman Beth | 代扣税 (F) | Common Stock | 8,803 | USD 7.27 | USD 63,998 | SEC 申报 ↗ |
| 2026-01-23 | Zelnick Kaufman Beth | 奖励／授予 (A) | Common Stock | 72,820 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-23 | Todisco Joseph | 代扣税 (F) | Common Stock | 27,306 | USD 7.27 | USD 198,515 | SEC 申报 ↗ |
| 2026-01-23 | Todisco Joseph | 奖励／授予 (A) | Common Stock | 225,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-23 | Hurlburt Elizabeth | 代扣税 (F) | Common Stock | 10,778 | USD 7.27 | USD 78,356 | SEC 申报 ↗ |
| 2026-01-23 | Hurlburt Elizabeth | 奖励／授予 (A) | Common Stock | 93,010 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-23 | Blum Susan | 代扣税 (F) | Common Stock | 9,767 | USD 7.27 | USD 71,006 | SEC 申报 ↗ |
| 2026-01-23 | Blum Susan | 奖励／授予 (A) | Common Stock | 72,820 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Dillione Janet | 卖出 (S) | Common Stock | 10,000 | USD 6.88 | USD 68,800 | SEC 申报 ↗ |
| 2026-01-17 | Todisco Joseph | 代扣税 (F) | Common Stock | 22,665 | USD 6.78 | USD 153,669 | SEC 申报 ↗ |
| 2026-01-16 | Todisco Joseph | 期权行权／转换 (M) | Common Stock | 29,585 | USD 3.38 | USD 99,997 | SEC 申报 ↗ |
| 2026-01-12 | Todisco Joseph | 代扣税 (F) | Common Stock | 17,417 | USD 7.15 | USD 124,532 | SEC 申报 ↗ |
| 2026-01-12 | Hurlburt Elizabeth | 代扣税 (F) | Common Stock | 5,794 | USD 7.15 | USD 41,427 | SEC 申报 ↗ |
| 2026-01-12 | Lefkowitz Steven W | 期权行权／转换 (M) | Common Stock | 15,000 | USD 5.63 | USD 84,450 | SEC 申报 ↗ |
| 2026-01-08 | Seckler Michael David | 奖励／授予 (A) | Common Stock | 133,156 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Zelnick Kaufman Beth | 代扣税 (F) | Common Stock | 11,333 | USD 12.16 | USD 137,809 | SEC 申报 ↗ |
| 2026-01-02 | Hurlburt Elizabeth | 代扣税 (F) | Common Stock | 10,895 | USD 12.16 | USD 132,483 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CRMD |
| CIK | 0001410098 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 160 transaction lines from 2020-01-07 to 2026-09-18 40 P purchase lines · 16 S sale lines · 104 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.